Evidence map›Paper›PMID 32163226›Full record

ArticleInfluenza and other respiratory viruses2020

Human respiratory syncytial virus and influenza seasonality patterns-Early findings from the WHO global respiratory syncytial virus surveillance.

Mandeep Chadha, Siddhivinayak Hirve, Christina Bancej, Ian Barr, Elsa Baumeister, Braulia Caetano, Malinee Chittaganpitch, Badarch Darmaa, Joanna Ellis, Rodrigo Fasce and 9 more

Open access · goldAbstract readComparative Study
In one paragraph

Article in Influenza and other respiratory viruses, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed, 3 pooled it
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 3 syntheses or guidelines pooled it, 138 citations in OpenAlex.

  1. Pooled it
  2. Determining the timing of respiratory syncytial virus (RSV) epidemics: a systematic review, 2016 to 2021; method categorisation and identification of influencing factors.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2024
    Pooled it
  3. Pooled it
  4. Trial
  5. Safety and Immunogenicity of Bivalent RSVpreF Vaccine Coadministered With Seasonal Inactivated Influenza Vaccine in Older Adults.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024
    Trial
  6. Article
  7. Review
  8. Article
  9. Article
  10. Noisy periodicity in tropical respiratory disease dynamics.medRxiv : the preprint server for health sciences · 2026
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 14 institutions in 14 countries.

Mandeep ChadhaNational Institute of Virology, Indian Council of Medical Research, Pune, India.
Siddhivinayak HirveGlobal Influenza Programme, World Health Organization, Geneva, Switzerland.ORCID 0000-0002-9651-7789
Christina BancejCentre for Immunization and Respiratory Infections, Public Health Agency of Canada, Ottawa, Canada.
Ian BarrVictorian Infectious Diseases Reference Laboratory, Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Elsa BaumeisterDepartamento Virologia, INEI-ANLIS "Carlos G Malbrán", Buenos Aires, Argentina.
Braulia CaetanoInstitute Oswaldo Cruz/FIOCRUZ, Rio de Janerio, Brazil.
Malinee ChittaganpitchDepartment of Medical Sciences, Ministry of Public Health, Nonthaburi, Thailand.
Badarch DarmaaVirology Laboratory, National Center for Communicable Diseases, Ulan baatar, Mongolia.
Joanna EllisVirus Reference Department, Public Health England, London, United Kingdom.
Rodrigo FasceSub-department of Viral Diseases, Instituto de Salud Pública de Chile, Santiago, Chile.
Herve KadjoDepartment of Epidemic Viruses, Institut Pasteur de Côte d'Ivoire, Abidjan, Côte d'Ivoire.
Sandra JacksonGlobal Influenza Programme, World Health Organization, Geneva, Switzerland.ORCID 0000-0002-1042-8882
Vivian LeungVictorian Infectious Diseases Reference Laboratory, Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Maria PisarevaLaboratory of Molecular Virology, Smorodintsev Research Institute of Influenza, St. Petersburg, Russian Federation.
Jocelyn MoyesCenter for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases, Johannesburg, South Africa.
Amel NaguibCentral Public Health Laboratory, Ministry of Health, Cairo, Egypt.
Almiro TivaneLaboratório de Isolamento Viral, Instituto Nacional de Saúde, Maputo, Mozambique.
Wenqing ZhangGlobal Influenza Programme, World Health Organization, Geneva, Switzerland.
WHO RSV Surveillance Group
World Meteorological Organization · CHVictorian Infectious Diseases Reference Laboratory · AUAdministración Nacional de Laboratorios e Institutos de Salud · ARFundação Oswaldo Cruz · BRICMR-National Institute of Virology · INInstituto de Salud Pública de Chile · CLInstituto Nacional de Saúde · MZMinistry of Health and Population · EGMinistry of Public Health · THNational Center for Communicable Diseases · MNPublic Health Agency of Canada · CAPublic Health England · GBResearch Institute of Influenza · RURespiratory and Meningeal Pathogens Research Unit · ZA

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundHuman respiratory syncytial virus (RSV) causes illnesses among all age groups and presents a burden to healthcare services. To better understand the epidemiology and seasonality of RSV in different geographical areas, the World Health Organization (WHO) coordinated a pilot initiative to access the feasibility of establishing RSV surveillance using the existing Global Influenza Surveillance and Response System (GISRS) platform.

objectivesTo describe and compare RSV and influenza seasonality in countries in the northern andsouthern temperate, and tropics during the period January 2017 to April 2019.

methodsFourteen countries in six WHO regions participating in the GISRS were invited for the pilot. Hospitalized patients presenting with severe acute respiratory illness (SARI), SARI without fever and outpatients presenting with acute respiratory illness (ARI) were enrolled from January 2017 to April 2019. The expected minimum sample size was 20 samples per week, year-round, per country. Real-time RT-PCR was used to detect RSV and influenza viruses. Results were uploaded to the WHO FluMart platform.

resultsAnnual seasonality of RSV was observed in all countries, which overlapped to a large extent with the influenza activity. In countries, in temperate regions RSV peaked in the autumn/winter months. In Egypt, a subtropical country, RSV activity peaked in the cooler season. In the tropical regions, RSV peaked during the rainy seasons.

conclusionEarly findings from the WHO RSV surveillance pilot based on the GISRS suggest annual seasonal patterns for of RSV circulation that overlap with influenza. RSV surveillance needs to be continued for several more seasons to establish seasonality patterns to inform prevention and control strategies.

Indexed as

Sentinel SurveillanceGlobal HealthHumansInfluenza, HumanOrthomyxoviridaePilot ProjectsRespiratory Syncytial Virus, HumanRespiratory Syncytial Virus InfectionsRespiratory Tract InfectionsSeasonsWorld Health OrganizationGlobal Influenza Surveillance and Response networkhuman respiratory syncytial virusinfluenzaseasonality

Identifiers

PMID32163226
PMCPMC7578323
OpenAlexW3010870929

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.